Skip to main content
Daily Report

Daily Ards Research Analysis

01/22/2025
3 papers selected
3 analyzed

Three studies advance ARDS-related respiratory care from systems to technology. A multi-country individual patient data analysis reveals large ICU mortality disparities in COVID-19 ARDS not explained by ventilator settings, pointing to system-level determinants. Preclinical closed-loop ventilation with decision-support fluids improves survival in burn + smoke–induced ARDS, and a neonatal pilot introduces an automated synchrony tool that quantifies and improves patient-ventilator matching during

Summary

Three studies advance ARDS-related respiratory care from systems to technology. A multi-country individual patient data analysis reveals large ICU mortality disparities in COVID-19 ARDS not explained by ventilator settings, pointing to system-level determinants. Preclinical closed-loop ventilation with decision-support fluids improves survival in burn + smoke–induced ARDS, and a neonatal pilot introduces an automated synchrony tool that quantifies and improves patient-ventilator matching during noninvasive support.

Research Themes

  • Cross-country outcomes and health-system determinants in COVID-19 ARDS
  • Closed-loop ventilation and decision-support fluid resuscitation in ARDS
  • Automated assessment of patient-ventilator synchrony during neonatal NIV

Selected Articles

1. CLOSED-LOOP VENTILATION AND OXYGENATION WITH DECISION SUPPORT FLUID RESUSCITATION TO TREAT MAJOR BURN INJURY WITH SMOKE-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME.

7.3Level VRCT
Shock (Augusta, Ga.) · 2025PMID: 39840968

In a conscious ovine model of burn plus smoke–induced ARDS, automated control of FiO2/PEEP and ventilation with decision-support fluid resuscitation improved static compliance, lowered driving pressure, and increased survival compared with manual settings. The closed-loop strategy yielded a higher net fluid balance without adverse interaction with automated PEEP control.

Impact: This preclinical randomized study demonstrates that closed-loop ventilatory control paired with decision-support resuscitation can improve survival in severe inhalation-injury ARDS, supporting translational efforts toward ICU automation.

Clinical Implications: Supports feasibility of automated FiO2/PEEP titration during aggressive resuscitation after burns; motivates early-phase human feasibility/safety trials and integration of closed-loop control in ventilators.

Key Findings

  • Closed-loop group had significantly higher PEEP and minute ventilation percentage and improved static lung compliance compared with controls.
  • Driving pressure was significantly lower and survival rate was higher in the closed-loop group.
  • Net fluid balance at 48 hours was higher with closed-loop control, without adverse interaction between automated PEEP and fluid management.

Methodological Strengths

  • Randomized allocation in a clinically relevant conscious large-animal model
  • Continuous cardiopulmonary monitoring over 48 hours with predefined automation protocols

Limitations

  • Preclinical animal model limits external validity to human ICU settings
  • Short observation window (48 hours) and small sample size (n=17) may overestimate effect sizes

Future Directions: Conduct human feasibility and safety trials of closed-loop FiO2/PEEP control with integrated fluid resuscitation decision support; evaluate longer-term outcomes and interaction with sedation, hemodynamics, and lung injury heterogeneity.

Introduction: The understanding of the interaction of closed-loop control of ventilation and oxygenation, specifically fraction of inspired oxygen (FiO 2 ) and positive end-expiratory pressure (PEEP), and fluid resuscitation after burn injury and acute lung injury from smoke inhalation is limited. We compared the effectiveness of FiO 2 , PEEP, and ventilation adjusted automatically using adaptive support ventilation (ASV) and decision support fluid resuscitation based on urine output in a clinically relevant conscious ovine model of lung injury secondary to combined smoke inhalation and major burn injury. Methods: Sheep were subjected to burn and smoke inhalation injury under deep anesthesia and analgesia. After injury, sheep were randomly allocated to two groups. 1) Closed-loop group: automated mechanical ventilation (ASV), oxygen FiO 2 and PEEP (n = 9); and 2) control group: mechanically ventilated with standard ASV mode (n = 8). FiO 2 , PEEP, and the percentage of the minute volume (%MV) were automatically adjusted in group 1, whereas PEEP was held at 5 cmH 2 O, and FiO 2 and %MV were manually adjusted in group 2. Decision support fluid resuscitation was guided based on urine output. Cardiopulmonary hemodynamics were monitored for 48 h. Results: There were no differences in body weight and the severity of smoke injury between the two groups. The closed-loop group resulted in significantly higher PEEP, %MV, static lung compliance, and survival rate; the driving pressure was significantly lower compared to the control group. In the closed-loop group, the net fluid balance at 48 h was significantly greater than in the control group. Conclusion: Closed-loop ventilation and oxygenation with decision support fluid resuscitation improve lung mechanics and survival in sheep with combined burn and smoke inhalation. There were no negative interactions observed between automated PEEP control and fluid management.

2. Epidemiology, Ventilation Management, and Outcomes in Invasively Ventilated Coronavirus Disease 2019 Patients: An Analysis of Four Observational Studies in Four Countries on Two Continents.

6.7Level IIICohort
The American journal of tropical medicine and hygiene · 2025PMID: 39842032

Pooling individual patient data from four national cohorts (n=6,702), ICU mortality for COVID-19 ARDS was markedly higher in Argentina/Brazil than in the Netherlands/Spain despite small differences in ventilation strategies. Propensity score weighting and matching confirmed robust differences, suggesting system-level or resource-related contributors beyond case-mix and ventilator settings.

Impact: This large, cross-country IPD analysis identifies major international disparities in COVID-19 ARDS outcomes not attributable to ventilator management, redirecting attention to health-system capacity, staffing, and access to adjunctive therapies.

Clinical Implications: Benchmarking outcomes across systems can inform resource allocation, surge planning, and quality improvement; clinicians should consider system-level constraints when interpreting ARDS mortality and prioritize comprehensive bundles beyond ventilator settings.

Key Findings

  • ICU mortality was significantly higher in Argentina (59.6%) and Brazil (56.6%) versus the Netherlands (32.1%) and Spain (34.7%) after adjustment (P<0.001).
  • Ventilation management differences between countries were small, suggesting limited explanatory power for outcome gaps.
  • Ventilator-free days at day 60 were higher in the Netherlands and Spain; propensity score matching confirmed outcome differences.

Methodological Strengths

  • Individual patient data meta-analysis across four countries with large sample size (n=6,702)
  • Robust confounding control using propensity score weighting and matching

Limitations

  • Observational design with potential residual confounding and unmeasured system-level variables
  • Heterogeneity in data sources and care pathways across countries

Future Directions: Decompose system-level contributors (staffing ratios, ICU strain, adjunct access) via linked administrative/clinical datasets; evaluate effects of standardized ARDS bundles and resource augmentation in LMIC settings.

Epidemiology, ventilator management, and outcomes in patients with acute respiratory distress syndrome (ARDS) because of coronavirus disease 2019 (COVID-19) have been described extensively but have never been compared between countries. We performed an individual patient data analysis of four observational studies to compare epidemiology, ventilator management, and outcomes. We used propensity score weighting to control for confounding factors. The analysis included 6,702 patients: 1,500 from Argentina, 844 from Brazil, 975 from the Netherlands, and 3,383 from Spain. There were substantial differences in baseline characteristics between countries. There were small differences in ventilation management. Intensive care unit mortality was higher in Argentina and Brazil compared with the Netherlands and Spain (59.6% and 56.6% versus 32.1% and 34.7%; P <0.001). The median number of days free from ventilation and alive at day 28 was equally low (0 [0-7], 0 [0-18], 1 [0-16], and 0 [0-16] days, respectively; P = 0.03), and the median number of days free from ventilation and alive at day 60 was higher in the Netherlands and Spain (0 [0-37], 0 [0-50], 33 [0-48], and 26 [0-48] days, respectively; P <0.001). Propensity score matching confirmed the outcome differences. Thus, the outcome of COVID-19 ARDS patients in Argentina and Brazil was substantially worse compared with that of patients in the Netherlands and Spain. It is unlikely that this results from differences in case mix or ventilation management.

3. A New Tool to Assess Patient-Ventilator Synchrony in Preterm Infants Receiving Non-Invasive Ventilation: A Randomized Crossover Pilot Study.

6.3Level IIRCT
Neonatology · 2025PMID: 39837293

The SyncNIV automated algorithm quantified patient-ventilator synchrony in preterm infants and showed significantly higher i-SI during nSIPPV versus nIPPV in a randomized crossover pilot (n=14). The tool processed over 90,000 combined breaths/inflations, supporting its feasibility for real-time monitoring and parameter optimization.

Impact: Introduces an automated, objective synchrony metric for neonatal NIV, enabling bedside quantification that could guide mode/setting choices and improve comfort and efficacy.

Clinical Implications: Bedside synchrony monitoring may help select nSIPPV over nIPPV when appropriate and fine-tune parameters to reduce work of breathing and NIV failure risk.

Key Findings

  • SyncNIV analyzed 43,304 ventilator inflations and 50,221 patient breaths in 14 preterm infants.
  • Instant Synchrony Index was significantly higher with nSIPPV (median ~55%) versus nIPPV (median ~40%) (p<0.05).
  • Demonstrated feasibility of automated, breath-by-breath synchrony monitoring using a custom signal-analysis algorithm.

Methodological Strengths

  • Randomized crossover design controlling for inter-subject variability
  • Objective, algorithm-based synchrony metric with large breath-level dataset

Limitations

  • Small single-center pilot (n=14) limits generalizability
  • Physiological endpoints without assessment of clinical outcomes (e.g., NIV failure, BPD)

Future Directions: Prospective multicenter validation with clinical endpoints; integration into ventilator software for real-time feedback and closed-loop triggering; assessment of impact on NIV failure and long-term outcomes.

INTRODUCTION: Nasal synchronized intermittent positive pressure ventilation (nSIPPV) is an effective non-invasive ventilation technique, especially for preterm infants. Patient-ventilator synchrony is essential for providing effective respiratory support; however, no automated system is currently available for monitoring this parameter. A new tool for automatic assessment of patient-ventilator synchrony, the SyncNIV system, was developed and applied in this pilot study to evaluate differences between nSIPPV and non-synchronized nasal intermittent positive pressure ventilation (nIPPV) in preterm infants with respiratory distress. METHODS: This study involved designing a custom algorithm for signal analysis. Data were collected through a polygraph that could simultaneously gather respiratory data from the patients and the ventilator. Patient-ventilator synchrony was evaluated by applying the SyncNIV system in a randomized crossover study designed to compare nSIPPV and nIPPV. The primary outcome was the mean instant Synchrony Index (i-SI), defined as the portion of the inspiration effort sustained by ventilator inflation, expressed as a percentage. RESULTS: Fourteen infants with a median (IQR) gestational age of 28.6 (25.6-30.3) were enrolled. We analyzed 43,304 ventilator inflations and 50,221 patient breaths. The i-SI was 54.69% (44.49-60.09) in nSIPPV and 39.54% (33.40-48.75) in nIPPV, p < 0.05. CONCLUSION: The SyncNIV system confirmed better i-SI during nSIPPV than during nIPPV, demonstrating its effectiveness in assessing the differences between these two modes of non-invasive ventilation in preterm infants. The SyncNIV system could be a useful tool for optimizing the ventilation parameters and improving the effectiveness and comfort of respiratory support systems.